RECORD // Company

Monopar Therapeutics

Built 2026-11-22T05:01:38Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Matched by name only, not merged (3)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Monopar Therapeutics · Ctgov · same registered legal name as 'Monopar Therapeutics' Possible match based on name, not a shared identifier. Compare the records. Compare
  • MONOPAR THERAPEUTICS · East licences · same registered legal name as 'Monopar Therapeutics' Possible match based on name, not a shared identifier. Compare the records. Compare
  • MONOPAR THERAPEUTICS INC. · Ny corps · same registered legal name as 'Monopar Therapeutics' Possible match based on name, not a shared identifier. Compare the records. Compare

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001437749-26-036384

ItemValuePeriodFormFiledAccessionReport
Revenue$09 months ended 2026-09-3010-Q2026-11-120001437749-26-0363842026-11-22 05:01 UTCReport an error
Net income (loss)$-6,196,4753 months ended 2026-09-3010-Q2026-11-120001437749-26-0363842026-11-22 05:01 UTCReport an error
Cash and cash equivalents$52,634,362at 2026-09-3010-Q2026-11-120001437749-26-0363842026-11-22 05:01 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001645469
Ticker
MNPR
EIN
320463781
CUSIP
61023L207
Record ID
sx:sec:0001645469

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

36 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 05:01 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-16SEC EDGAR company profile2026-11-22 05:01 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-22 05:01 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 05:01 UTCReport an error
Business address1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 600912026-11-16SEC EDGAR company profile2026-11-22 05:01 UTCReport an error
ExchangesNasdaq2026-11-16SEC EDGAR company profile2026-11-22 05:01 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$02025-12-3110-K, XBRL Revenues2026-11-22 05:01 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-13,716,8942025-12-3110-K, XBRL NetIncomeLoss2026-11-22 05:01 UTCReport an error
Total assets (at 2025-12-31)$140,717,7092025-12-3110-K, XBRL Assets2026-11-22 05:01 UTCReport an error
Stockholders' equity (at 2025-12-31)$137,827,5532025-12-3110-K, XBRL StockholdersEquity2026-11-22 05:01 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$61,833,5522025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 05:01 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-12,201,2912025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 05:01 UTCReport an error
Operating lease liabilities (at 2025-12-31)$245,4892025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 05:01 UTCReport an error
Form D total offering amount (D filed 2017-08-23)$4,500,0002017-08-23D2026-11-22 05:01 UTCReport an error
Form D total amount sold (D filed 2017-08-23)$02017-08-23D2026-11-22 05:01 UTCReport an error
Form D industry groupBiotechnology2017-08-23D2026-11-22 05:01 UTCReport an error
Form D revenue rangeDecline to Disclose2017-08-23D2026-11-22 05:01 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-12)On November 12, 2026, Monopar Therapeutics Inc. ("Monopar" or the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Item 2.02 and the exhibit hereto are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference…2026-11-12SEC EDGAR 8-K 0001437749-26-036385 (text as filed, excerpt)2026-11-22 05:01 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-12)On August 12, 2026, Monopar Therapeutics Inc. ("Monopar" or the “Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Item 2.02 and the exhibit hereto are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in…2026-08-12SEC EDGAR 8-K 0001437749-26-027165 (text as filed, excerpt)2026-11-22 05:01 UTCReport an error
Employer name (as filed)Monopar Therapeutics Inc2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 05:01 UTCReport an error
Certified LCAs12026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 05:01 UTCReport an error
Certified LCAs later withdrawn02026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 05:01 UTCReport an error
Total worker positions on certified LCAs12026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 05:01 UTCReport an error
Top job titles (title, LCA count)CMC Operations Associate (1)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 05:01 UTCReport an error
Wage offered, annualized (n, min, median, max)median $98,000 (range $98,000-$98,000, 1 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 05:01 UTCReport an error
Worksite statesIL2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 05:01 UTCReport an error
Largest institutional holder #1 (13F as filed): Jupiter Topco LLC$121,699,9652026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error
Largest institutional holder #2 (13F as filed): RA CAPITAL MANAGEMENT, L.P.$61,776,6962026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error
Largest institutional holder #3 (13F as filed): BlackRock, Inc.$32,297,1512026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error
Largest institutional holder #4 (13F as filed): DEERFIELD MANAGEMENT COMPANY, L.P.$29,975,5502026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error
Largest institutional holder #5 (13F as filed): Saturn V Capital Management LP$28,885,8582026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error
Largest institutional holder #6 (13F as filed): Siren, L.L.C.$25,010,2262026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error
Largest institutional holder #7 (13F as filed): ADAR1 Capital Management, LLC$20,147,1212026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error
Largest institutional holder #8 (13F as filed): Polar Capital Holdings Plc$19,857,6852026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error
Largest institutional holder #9 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$19,417,1412026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error
Largest institutional holder #10 (13F as filed): ADAGE CAPITAL PARTNERS GP, L.L.C.$19,369,3652026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:01 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.